Home Bromides 29334-16-5
29334-16-5,MFCD00016851
Catalog No.:AA002Y0D

29334-16-5 | (4-Bromophenyl)(phenyl)methanol

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
96%
in stock  
$29.00   $20.00
- +
5g
96%
in stock  
$62.00   $44.00
- +
25g
97%
in stock  
$158.00   $110.00
- +
100g
97%
in stock  
$515.00   $360.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA002Y0D
Chemical Name:
(4-Bromophenyl)(phenyl)methanol
CAS Number:
29334-16-5
Molecular Formula:
C13H11BrO
Molecular Weight:
263.1298
MDL Number:
MFCD00016851
SMILES:
Brc1ccc(cc1)C(c1ccccc1)O
NSC Number:
89817
Properties
Properties
 
BP:
381.5°C at 760 mmHg  
Form:
Solid  
MP:
61 °C  
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
181  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
1  
XLogP3:
3.4  

Downstream Synthesis Route

[1]JournalofMedicinalChemistry,2000,vol.43,p.3878-3894

[2]BioorganicandMedicinalChemistryLetters,2010,vol.20,p.1816-1818

[3]Patent:WO2013/25733,2013,A1.Locationinpatent:Paragraph0426

[4]JournaloftheAmericanChemicalSociety,1928,vol.50,p.1804

[5]JournaloftheAmericanChemicalSociety,1928,vol.50,p.1804

[6]JournalofOrganicChemistry,1967,vol.32,p.2692-2695

[7]JournalofMedicinalChemistry,1995,vol.38,p.3933-3940

[8]BioorganicandMedicinalChemistryLetters,2004,vol.14,p.2519-2525

[9]JournalofChemistry,2016,vol.2016

[10]OrganicLetters,2017,vol.19,p.918-921

[1]AngewandteChemie,1989,vol.101,p.329-330

[2]ChemistryLetters,2011,vol.40,p.495-497

[3]CatalysisLetters,2019,vol.149,p.2142-2157

[4]OrganicandBiomolecularChemistry,2018,vol.16,p.5094-5096

[5]MonatsheftefurChemie,2003,vol.134,p.1365-1371

[6]NewJournalofChemistry,2017,vol.41,p.12736-12745

[7]AdvancedSynthesisandCatalysis,2015,vol.357,p.3115-3120

[8]OrganicLetters,2011,vol.13,p.98-101

[9]Organometallics,2013,vol.32,p.6631-6634

[10]JournalofOrganicChemistry,1980,vol.45,p.4126-4129

[11]GreenChemistry,2009,vol.11,p.683-685

[12]RSCAdvances,2014,vol.4,p.27955-27962

[13]ChemicalCommunications,1997,p.1119-1120

[14]JournalofMedicinalChemistry,2015,vol.58,p.8564-8572

[15]TetrahedronLetters,2004,vol.45,p.2003-2007

[16]OrganicandBiomolecularChemistry,2019,vol.17,p.6007-6014

[17]Organometallics,2019,vol.38,p.4387-4391

[18]JournalofOrganicChemistry,1993,vol.58,p.7138-7142

[19]JournaloftheAmericanChemicalSociety,1939,vol.61,p.3564

[20]JournalofOrganicChemistry,1948,vol.13,p.916,920

[21]JournaloftheAmericanChemicalSociety,1929,vol.51,p.3382

[22]RecueildesTravauxChimiquesdesPays-Bas,1908,vol.27,p.340

[23]RecueildesTravauxChimiquesdesPays-Bas,1908,vol.27,p.340

[24]RecueildesTravauxChimiquesdesPays-Bas,1910,vol.29,p.153

[25]RecueildesTravauxChimiquesdesPays-Bas,1919,vol.38,p.121

[26]ComptesRendusHebdomadairesdesSeancesdel'AcademiedesSciences,1945,vol.220,p.460

[27]JournalofOrganicChemistry,1967,vol.32,p.2692-2695

[28]JournaloftheChemicalSociety.PerkintransactionsII,1983,p.949-954

[29]IndianJournalofChemistry,SectionA:Inorganic,Physical,TheoreticalandAnalytical,1981,vol.20,p.998-1001

[30]JournalofOrganicChemistry,1993,vol.58,p.5907-5914

[31]CanadianJournalofChemistry,1998,vol.76,p.919-928

[32]BioorganicandMedicinalChemistryLetters,2004,vol.14,p.3691-3695

[33]OrganicLetters,2002,vol.4,p.4297-4300

[34]Pharmazie,2007,vol.62,p.174-178

[35]OrganicLetters,2007,vol.9,p.2027-2030

[36]EuropeanJournalofOrganicChemistry,2007,p.4642-4645

[37]Lettersindrugdesignanddiscovery,2010,vol.7,p.661-664

[38]ChemicalCommunications,2015,vol.51,p.15106-15109

[39]JournaloftheAmericanChemicalSociety,2016,vol.138,p.6940-6943

[40]JournalofChemistry,2016,vol.2016

[41]JournalofOrganometallicChemistry,2018,vol.876,p.57-65

[42]Patent:WO2004/22526,2004,A1.Locationinpatent:Page85-86

[43]DaltonTransactions,2019,vol.48,p.11838-11847

[1]RecueildesTravauxChimiquesdesPays-Bas,1908,vol.27,p.353

[1]Bull.Sect.Sci.Acad.Roum.,12Nr.4/5<1929>7,15,

[2]AdvancedSynthesisandCatalysis,2018,vol.360,p.4330-4335

[1]JournaloftheAmericanChemicalSociety,1928,vol.50,p.1811

Literature

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:29334-16-5 Molecular Formula|29334-16-5 MDL|29334-16-5 SMILES|29334-16-5 (4-Bromophenyl)(phenyl)methanol |Organic_Building_Blocks